Plandai Biotechnology Marketing of First Product to Customers Should Be a Cinch With Proven Higher Bioavailability
October 17, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - October 17, 2014) - Plandaí Biotechnology (OTCQB: PLPL) began to lay out its initial plan this week explaining just how the company will get its first product, a green tea...
Plandai Biotechnology, Inc. Announces Update on Factory and Expected Plan to Market First Phytofare(TM) Product
October 15, 2014 09:27 ET
|
Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - October 15, 2014) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) ("Plandaí" or "the Company"), a developer of highly bioavailable plant extracts for industries including...
FDA Exemption Has Plandai Biotechnology Heading Into Third Quarter Ready to Commence Sales of First Phytofare(TM) Product
June 26, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Jun 26, 2014) - Plandaí Biotechnology (OTCQB: PLPL) recently learned that it qualifies for an exemption that will allow the company to commence sales of its...
Plandaí Biotechnology's VP of Global Marketing Jamen Shively Discusses Future of Cannabis at the Company
May 13, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - May 13, 2014) - Plandaí Biotechnology (OTCQB: PLPL) has plans to develop and market a cannabis extract once the political climate in the US sorts itself...
Plandai Biotechnology up for $2.5 Million Grant in Continued Support From South African Government
May 02, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - May 2, 2014) - Plandaí Biotechnology (OTCQB: PLPL) could soon receive another injection of money from the South African government, and this time it's in the form...
Plandai Biotechnology Recruiting Now for Human Clinical Trials to Begin in May
April 30, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Apr 30, 2014) - Plandaí Biotechnology (OTCQB: PLPL) has been given the go-ahead to conduct human clinical trials in a 3-month study that will compare the oral...
Plandai Biotechnology Closer to Unzipping the Magic of Phytofare in New Facility
April 04, 2014 08:30 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Apr 4, 2014) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) welcomes the month of April with a brand new state of the art production facility that is due to be fully...
Plandai Biotechnology "Waiver" Could Dramatically Expedite Medical Marijuana Research
March 31, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Mar 31, 2014) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) has a real opportunity to advance its medical marijuana research, and in doing so, it could be one of the...
Plandai Biotechnology Management Discusses Progress of Company's Cannabis Extracts
March 28, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Mar 28, 2014) - Last month Plandaí Biotechnology, Inc. (OTCQB: PLPL) closed a licensing agreement with Diego Pellicer, Inc. that will allow the company to use the...
Plandai Biotechnology's Human Clinical Trials Offer Significant Proof of Concept
March 26, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Mar 26, 2014) - What may have been lost in Plandaí Biotechnology's (OTCQB: PLPL) recently reported results from its human clinical trial to test the anti-aging...